In a market moving as quickly as AI, investors say that they aren't looking for companies with technology moats, but rather ...
Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, today announced its launch with $120 million in funding. The ...
Bengaluru-based payment solutions provider Juspay is in discussions with Warburg Pincus, Kedaara Capital, and Norwest Venture ...
Providence launched its venture arm in 2015. Allumia focuses on health care tech and originally managed funds only for ...
Private-equity veteran Richard Lichter launched Causeway Equity Partners, looking to capitalize on the growing numbers of ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. | The Fierce Biotech Fundraising Tracker records ...